RxISK drug safety petition asks AbbVie and InterMune to stop blocking access to drug clinical trial data

Print Friendly
September 13, 2013 | 1 Comment

Comments

  1. I’m not sure if I signed this particular petition, on your behalf for our behalf (so to speak awkwardly), but if it can be routed to my email address, I most certainly will! One of the drugs I am now tapering off was known to medical professionals,,of what would seem the highest of repute, as non addictive. As a physician actively involved in psych drugs, I am sure you are aware of the implications of its continued prescription for over 31 years BOTH PHYSICALLY AND PSYCHOLOGICALLY. That was in 1981 when Xanax was released. I know my physicians went by the information they were provided as did their peers. If access to accurate and full benefits versus adversities were either continued or further blocked, there only will end up more casualties like myself and so many many others. This is a tragedy of epic proportions and any move to only further the suffering inadvertently perpetuated by actions to increase the difficulty of objective study of unabridged statistic would only be criminal.

    Thank you for for allowing me to both validate what my life has become and why but also for the many others now and in the future who may find themselves equally at every imaginable disadvantage because of ignorance.

Leave a Reply